---
title: Group Education Curriculum for Older Teens With Type 1 Diabetes
nct_id: NCT03147274
overall_status: COMPLETED
phase: NA
sponsor: "Boston Children's Hospital"
study_type: INTERVENTIONAL
primary_condition: Type 1 Diabetes Mellitus
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT03147274.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT03147274"
ct_last_update_post_date: 2019-04-17
last_seen_at: "2026-05-12T06:05:23.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Group Education Curriculum for Older Teens With Type 1 Diabetes

**Official Title:** Evaluation of a Group Curriculum to Improve Self-Management Adherence and Transition Readiness in Older Teens With Type 1 Diabetes

**NCT ID:** [NCT03147274](https://clinicaltrials.gov/study/NCT03147274)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 40
- **Lead Sponsor:** Boston Children's Hospital
- **Conditions:** Type 1 Diabetes Mellitus
- **Start Date:** 2017-05-03
- **Completion Date:** 2019-02-21
- **CT.gov Last Update:** 2019-04-17

## Brief Summary

SMART T1D is a research study that offers interactive diabetes education for teens with type 1 diabetes in peer groups led by diabetes nurse educators. Participants in the study will be randomly assigned to either receive three of the group sessions in addition to their routine clinic care or to receive their usual diabetes clinic care.

## Detailed Description

The objective of this 12-month pilot randomized controlled trial is to evaluate the impact of a 3-session group educational curriculum, compared to standard care, on self-care adherence and transition readiness in adolescents with type 1 diabetes in the Boston Children's Hospital (BCH) Diabetes Program. Adolescents (15-18 years) with T1D will be randomized to receive a 3-session group curriculum ("SMART T1D" - Self-Management, Adherence and Readiness for Transition in T1D) in addition to usual care (intervention group) or to receive usual care with individual diabetes visits (control group) and electronic newsletters to match for attention.

## Eligibility

- **Minimum age:** 15 Years
- **Maximum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Enrolled in the pediatric diabetes clinic at Boston Children's Hospital
* Age 15-18 years at enrollment
* Diabetes duration \>1 year
* Ability to speak/read English
* Visits to any BCH Diabetes Program site ≥1 times over the past 6 months
* Hemoglobin A1c at clinic visit prior to enrollment 7.5%-11%

Exclusion Criteria:

* Major medical or psychiatric comorbidities
* Established patients of one of the diabetes nurse educators delivering the intervention
```

## Arms

- **Intervention Group** (EXPERIMENTAL) — Participants in this group will receive 3 group education sessions led by a diabetes nurse educator in addition to standard care.
- **Control Group** (NO_INTERVENTION) — These participants will receive no intervention. They will have clinic care as usual and will receive three diabetes newsletters to match for attention.

## Interventions

- **Intervention** (BEHAVIORAL) — Patients randomized to the intervention group will attend 3 SMART T1D group curriculum sessions over the study period, in addition to usual diabetes clinic care. Each interactive group session will last 2 hours and will be facilitated by a diabetes nurse educator.

## Primary Outcomes

- **Change from baseline self-care adherence at 12 months** _(time frame: 12 months)_ — Measured by the Self-Care Inventory-Revised (SCI-R)

## Secondary Outcomes

- **Change from baseline transition readiness at 12 months** _(time frame: 12 months)_
- **Change from baseline hemoglobin A1c at 12 months** _(time frame: 12 months)_

## Locations (1)

- Boston Children's Hospital, Boston, Massachusetts, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.boston children's hospital|boston|massachusetts|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT03147274.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT03147274*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*